Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes

INTRODUCTION: Gene expression analysis is used to subtype breast cancers such that the most aggressive tumors are identified, but translating this into clinical practice can be cumbersome. Our goal is to develop a universal biomarker that distinguishes patients at high risk across all breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Habibi, Golareh, Leung, Samuel, Law, Jennifer H, Gelmon, Karen, Masoudi, Hamid, Turbin, Dmitry, Pollak, Michael, Nielsen, Torsten O, Huntsman, David, Dunn, Sandra E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614522/
https://www.ncbi.nlm.nih.gov/pubmed/18925950
http://dx.doi.org/10.1186/bcr2156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614522/
https://www.ncbi.nlm.nih.gov/pubmed/18925950
http://dx.doi.org/10.1186/bcr2156

Ejemplares similares